AIMS: The DETECT study was performed to obtain representative data about the frequency, distribution, and treatment of patients with coronary artery disease (CAD) in the primary care setting in Germany. METHODS AND RESULTS: The DETECT study was a cross-sectional clinical- epidemiological survey of a nationally representative sample of 3795 primary care offices and 55,518 patients. Overall, 12.4% of patients were diagnosed with CAD. Stable angina pectoris and myocardial infarction were the most frequent (4.2%) subgroups, followed by status post (s/p) percutaneous coronary interventions (PCI, 3.0%) and s/p coronary bypass surgery (2.2%). Patients with CAD were prescribed AT1 receptor antagonists (in 19.4% of cases), beta blockers (57.2%), ACE inhibitors (49.9%), antiplatelet agents (52.7%), statins (43.0%), and long-term nitrates (24.5%). When comparing all CAD patients with social health care insurance to those who had private insurance, private patients had significantly higher rates of revascularisation procedures and use of preventive medications. CONCLUSION: Great potential remains for improving secondary prevention in primary care in Germany to reduce the risk of further coronary or vascular events, especially in patients with social health care insurance.
AIMS: The DETECT study was performed to obtain representative data about the frequency, distribution, and treatment of patients with coronary artery disease (CAD) in the primary care setting in Germany. METHODS AND RESULTS: The DETECT study was a cross-sectional clinical- epidemiological survey of a nationally representative sample of 3795 primary care offices and 55,518 patients. Overall, 12.4% of patients were diagnosed with CAD. Stable angina pectoris and myocardial infarction were the most frequent (4.2%) subgroups, followed by status post (s/p) percutaneous coronary interventions (PCI, 3.0%) and s/p coronary bypass surgery (2.2%). Patients with CAD were prescribed AT1 receptor antagonists (in 19.4% of cases), beta blockers (57.2%), ACE inhibitors (49.9%), antiplatelet agents (52.7%), statins (43.0%), and long-term nitrates (24.5%). When comparing all CAD patients with social health care insurance to those who had private insurance, private patients had significantly higher rates of revascularisation procedures and use of preventive medications. CONCLUSION: Great potential remains for improving secondary prevention in primary care in Germany to reduce the risk of further coronary or vascular events, especially in patients with social health care insurance.
Authors: Andra L Blomkalns; Anita Y Chen; Judith S Hochman; Eric D Peterson; Kelly Trynosky; Deborah B Diercks; Gerard X Brogan; William E Boden; Matthew T Roe; E Magnus Ohman; W Brian Gibler; L Kristin Newby Journal: J Am Coll Cardiol Date: 2005-03-15 Impact factor: 24.094
Authors: Tobias Heer; Rudolf Schiele; Steffen Schneider; Anselm K Gitt; Harm Wienbergen; Martin Gottwik; Ulf Gieseler; Thomas Voigtländer; Karl E Hauptmann; Stefan Wagner; Jochen Senges Journal: Am J Cardiol Date: 2002-03-01 Impact factor: 2.778
Authors: Wissam A Jaber; Ryan J Lennon; Verghese Mathew; David R Holmes; Amir Lerman; Charanjit S Rihal Journal: J Am Coll Cardiol Date: 2005-09-23 Impact factor: 24.094
Authors: K A Schulman; J A Berlin; W Harless; J F Kerner; S Sistrunk; B J Gersh; R Dubé; C K Taleghani; J E Burke; S Williams; J M Eisenberg; J J Escarce Journal: N Engl J Med Date: 1999-02-25 Impact factor: 91.245
Authors: Sigmund Silber; Per Albertsson; Francisco F Avilés; Paolo G Camici; Antonio Colombo; Christian Hamm; Erik Jørgensen; Jean Marco; Jan-Erik Nordrehaug; Witold Ruzyllo; Philip Urban; Gregg W Stone; William Wijns Journal: Eur Heart J Date: 2005-03-15 Impact factor: 29.983
Authors: J Klotsche; D M Leistner; L Pieper; D Pittrow; A M Zeiher; H-U Wittchen Journal: Int J Methods Psychiatr Res Date: 2011-06 Impact factor: 4.035
Authors: Anselm K Gitt; Claus Jünger; Christina Jannowitz; Barbara Karmann; Jochen Senges; Kurt Bestehorn Journal: Clin Res Cardiol Date: 2010-10-21 Impact factor: 5.460
Authors: Heribert Schunkert; Susanne Moebus; Jens Hanisch; Peter Bramlage; Elisabeth Steinhagen-Thiessen; Hans Hauner; Joachim Weil; Jürgen Wasem; Karl-Heinz Jöckel Journal: Clin Res Cardiol Date: 2008-07-21 Impact factor: 5.460
Authors: K Drechsler; S Fikenzer; U Sechtem; E Blank; G Breithardt; U Zeymer; J Niebauer Journal: Clin Res Cardiol Date: 2008-02-04 Impact factor: 5.460